Yu Zhang1,2, I-Wei Wu1,2, Shannon Buckley1,2, Christopher S Coffey3, Eric Foster3, Susan Mendick4, John Seibyl4, Norbert Schuff1,2. 1. Center for Imaging of Neurodegenerative Diseases, San Francisco VA Medical Center, San Francisco, CA, USA. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. 3. Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. 4. Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging, LLC (MNI), New Haven, CT, USA.
Abstract
BACKGROUND: Parkinson's disease (PD) is histopathologically characterized by the loss of dopamine neurons in the substantia nigra pars compacta. The depletion of these neurons is thought to reduce the dopaminergic function of the nigrostriatal pathway, as well as the neural fibers that link the substantia nigra to the striatum (putamen and caudate), causing a dysregulation in striatal activity that ultimately leads to lack of movement control. Based on diffusion tensor imaging, visualizing this pathway and measuring alterations of the fiber integrity remain challenging. The objectives were to 1) develop a diffusion tensor tractography protocol for reliably tracking the nigrostriatal fibers on multicenter data; 2) test whether the integrities measured by diffusion tensor imaging of the nigrostriatal fibers are abnormal in PD; and 3) test whether abnormal integrities of the nigrostriatal fibers in PD patients are associated with the severity of motor disability and putaminal dopamine binding ratios. METHODS: Diffusion tensor tractography was performed on 50 drug-naïve PD patients and 27 healthy control subjects from the international multicenter Parkinson's Progression Marker Initiative. RESULTS: Tractography consistently detected the nigrostriatal fibers, yielding reliable diffusion measures. Fractional anisotropy, along with radial and axial diffusivity of the nigrostriatal tract, showed systematic abnormalities in patients. In addition, variations in fractional anisotropy and radial diffusivity of the nigrostriatal tract were associated with the degree of motor deficits in PD patients. CONCLUSION: Taken together, the findings imply that the diffusion tensor imaging characteristic of the nigrostriatal tract is potentially an index for detecting and staging of early PD.
BACKGROUND:Parkinson's disease (PD) is histopathologically characterized by the loss of dopamine neurons in the substantia nigra pars compacta. The depletion of these neurons is thought to reduce the dopaminergic function of the nigrostriatal pathway, as well as the neural fibers that link the substantia nigra to the striatum (putamen and caudate), causing a dysregulation in striatal activity that ultimately leads to lack of movement control. Based on diffusion tensor imaging, visualizing this pathway and measuring alterations of the fiber integrity remain challenging. The objectives were to 1) develop a diffusion tensor tractography protocol for reliably tracking the nigrostriatal fibers on multicenter data; 2) test whether the integrities measured by diffusion tensor imaging of the nigrostriatal fibers are abnormal in PD; and 3) test whether abnormal integrities of the nigrostriatal fibers in PDpatients are associated with the severity of motor disability and putaminal dopamine binding ratios. METHODS: Diffusion tensor tractography was performed on 50 drug-naïve PDpatients and 27 healthy control subjects from the international multicenter Parkinson's Progression Marker Initiative. RESULTS: Tractography consistently detected the nigrostriatal fibers, yielding reliable diffusion measures. Fractional anisotropy, along with radial and axial diffusivity of the nigrostriatal tract, showed systematic abnormalities in patients. In addition, variations in fractional anisotropy and radial diffusivity of the nigrostriatal tract were associated with the degree of motor deficits in PDpatients. CONCLUSION: Taken together, the findings imply that the diffusion tensor imaging characteristic of the nigrostriatal tract is potentially an index for detecting and staging of early PD.
Authors: David S Tuch; Timothy G Reese; Mette R Wiegell; Nikos Makris; John W Belliveau; Van J Wedeen Journal: Magn Reson Med Date: 2002-10 Impact factor: 4.668
Authors: L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan Journal: J Neurol Neurosurg Psychiatry Date: 2007-07-05 Impact factor: 10.154
Authors: Carlos A Sanchez-Catasus; Nicolaas I Bohnen; Fang-Cheng Yeh; Nicholas D'Cruz; Prabesh Kanel; Martijn L T M Müller Journal: J Nucl Med Date: 2020-08-28 Impact factor: 10.057
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Michael Goldenberg; Lan Kong; Richard B Mailman; Young-Seoub Hong; Xuemei Huang Journal: Parkinsonism Relat Disord Date: 2021-02-24 Impact factor: 4.891
Authors: Wisberty J Gordián-Vélez; Dimple Chouhan; Rodrigo A España; H Isaac Chen; Jason A Burdick; John E Duda; D Kacy Cullen Journal: Brain Res Bull Date: 2021-07-28 Impact factor: 3.715
Authors: Sydni M Cole; Sasmit Sarangi; David Einstein; Malgorzata McMasters; Ron Alterman; Jeffrey Bruce; Lauren Hertan; Helen A Shih; Eric T Wong Journal: Surg Neurol Int Date: 2021-05-25